423 related articles for article (PubMed ID: 15010818)
1. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
[TBL] [Abstract][Full Text] [Related]
2. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
[TBL] [Abstract][Full Text] [Related]
3. Relationship between lipoxygenase and human testicular cancer.
Yoshimura R; Matsuyama M; Mitsuhashi M; Takemoto Y; Tsuchida K; Kawahito Y; Sano H; Nakatani T
Int J Mol Med; 2004 Mar; 13(3):389-93. PubMed ID: 14767568
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353
[TBL] [Abstract][Full Text] [Related]
5. Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor.
Yoshimura R; Inoue K; Kawahito Y; Mitsuhashi M; Tsuchida K; Matsuyama M; Sano H; Nakatani T
Int J Mol Med; 2004 Jan; 13(1):41-6. PubMed ID: 14654968
[TBL] [Abstract][Full Text] [Related]
6. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; MartÃnez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
7. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells.
Ding XZ; Iversen P; Cluck MW; Knezetic JA; Adrian TE
Biochem Biophys Res Commun; 1999 Jul; 261(1):218-23. PubMed ID: 10405349
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.
Pidgeon GP; Kandouz M; Meram A; Honn KV
Cancer Res; 2002 May; 62(9):2721-7. PubMed ID: 11980674
[TBL] [Abstract][Full Text] [Related]
9. Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer.
Segawa Y; Yoshimura R; Hase T; Nakatani T; Wada S; Kawahito Y; Kishimoto T; Sano H
Prostate; 2002 May; 51(2):108-16. PubMed ID: 11948965
[TBL] [Abstract][Full Text] [Related]
10. Lipoxygenase inhibitors prevent urological cancer cell growth.
Matsuyama M; Yoshimura R; Tsuchida K; Takemoto Y; Segawa Y; Shinnka T; Kawahito Y; Sano H; Nakatani T
Int J Mol Med; 2004 May; 13(5):665-8. PubMed ID: 15067367
[TBL] [Abstract][Full Text] [Related]
11. Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors.
Yoshimura R; Matsuyama M; Tsuchida K; Kawahito Y; Sano H; Nakatani T
J Urol; 2003 Nov; 170(5):1994-9. PubMed ID: 14532840
[TBL] [Abstract][Full Text] [Related]
12. Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells.
Ding XZ; Kuszynski CA; El-Metwally TH; Adrian TE
Biochem Biophys Res Commun; 1999 Dec; 266(2):392-9. PubMed ID: 10600514
[TBL] [Abstract][Full Text] [Related]
13. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.
Hoque A; Lippman SM; Wu TT; Xu Y; Liang ZD; Swisher S; Zhang H; Cao L; Ajani JA; Xu XC
Carcinogenesis; 2005 Apr; 26(4):785-91. PubMed ID: 15661803
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of proliferation of PC3 cells by the branched-chain fatty acid, 12-methyltetradecanoic acid, is associated with inhibition of 5-lipoxygenase.
Yang P; Collin P; Madden T; Chan D; Sweeney-Gotsch B; McConkey D; Newman RA
Prostate; 2003 Jun; 55(4):281-91. PubMed ID: 12712407
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA
Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292
[TBL] [Abstract][Full Text] [Related]
17. Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer.
Tang J; Wang Z; Li X; Li J; Shi H
Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):83-93. PubMed ID: 18437586
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression.
Pidgeon GP; Tang K; Cai YL; Piasentin E; Honn KV
Cancer Res; 2003 Jul; 63(14):4258-67. PubMed ID: 12874035
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
[TBL] [Abstract][Full Text] [Related]
20. Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase.
Ghosh J
Biochem Biophys Res Commun; 2004 Mar; 315(3):624-35. PubMed ID: 14975747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
